Genetic research
Researchers at the University of Genoa have made a significant breakthrough in cancer gene therapy, developing biomimetic hybrid vesicles that target colorectal cancer cells with high efficiency. This innovative approach combines the benefits of targeted drug delivery with the controlled preparation process, making it a promising strategy for treating cancer.
Genetic research
Investigators at King Saud University have made significant advancements in understanding the molecular mechanisms underlying uterine corpus endometrial carcinoma (UCEC), a common gynecological malignancy. By exploring the roles of immune-related genes, the research has shed light on potential diagnostic, prognostic, and therapeutic strategies for UCEC. The study identified COL1A1, ITGB1,
Genetic research
Research on biotechnology and cancer gene therapy in Tehran, Iran, has revealed the need for novel therapies in the treatment of neuroblastoma, a common pediatric cancer. Despite progress in initial treatments, high-risk cases of neuroblastoma remain challenging due to frequent relapse or resistance, with long-term survival for relapsed or refractory
Genetic research
The Saudi Food and Drug Authority has approved the first phase 1 clinical study of a locally developed, novel gene therapy using engineered T-cells (CAR T-cells) to treat patients with aggressive lymphoblastic leukemia. The therapy was developed and manufactured locally within a research environment at King Faisal Specialist Hospital and
Cancer research
Researchers from the First Hospital of China Medical University have made a groundbreaking discovery in the field of cancer gene therapy. By studying the microbiome within tumor tissues, they have found that microorganisms play a crucial role in regulating the tumor microenvironment and promoting the progression of solid tumors. The
Cancer research
Researchers at the University of Hong Kong have made significant progress in developing a novel colon cancer treatment that combines two therapeutic approaches: ferroptosis suppressor protein 1 (FSP1) gene silencing and photodynamic therapy. The study, published in ACS Nano, demonstrates the potential of photosensitive lipid nanoparticles (LNPs) to synergistically promote
Cancer research
Recent research from the University of Paris has highlighted the potential of microtubule-targeting agents (MTAs) in treating gliomas and neurodegenerative diseases. MTAs, which disrupt cell division and cell migration, have shown efficacy in tumour suppression and neuronal repair, but their use in the central nervous system (CNS) is hindered by
Genetic research
Researchers at Canada's Michael Smith Genome Sciences Centre have made a significant discovery in understanding cancer by identifying transcriptional patterns associated with cancer-related genes. By using random forest models, the team successfully pinpointed genes with unique cancer-related expression patterns, providing new avenues for targeted therapies. The study'
Cancer research
Researchers at the Chinese Academy of Sciences have made a significant breakthrough in cancer gene therapy with the development of a dendritic cell-liposome conjugate that efficiently reverses immunosuppressive tumor microenvironments, showing remarkable efficiency against colorectal cancer. This innovative approach eliminates tumor-infiltrated Fas MDSCs and enhances TAM phagocytosis in tumors, leading
Cancer research
A recent study published in Current Oncology reveals that astronauts are at a high risk of developing cancer due to exposure to high-linear energy transfer (LET) heavy ions during space missions. The research, funded by the National Aeronautics & Space Administration (NASA) and the NIH National Cancer Institute (NCI), found
Genetic research
A recent study published in the journal Medical Physics has provided new insights into the management of head and neck squamous cell carcinoma (HNSCC). Research conducted at the Affiliated BenQ Hospital of Nanjing Medical University in Jiangsu, People's Republic of China, has developed a radiomics-based model to predict
Genetic research
The Oklahoma Medical Research Foundation (OMRF) has received a significant grant from the National Institutes of Health (NIH) to study two fundamental DNA processes: transcription and replication. These processes are crucial for cells to grow and function properly, but errors in them can lead to genetic diseases, cancers, and birth
